Highfields Capital Management’s Allergan plc AGN Stock Holding History

Highfields Capital Management’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-37,500	Closed	-$7.14M	–	46
2018 Q3	$7.14M	Hold	37,500	–	–	0.13%	42
2018 Q2	$6.25M	Hold	37,500	–	–	0.07%	55
2018 Q1	$6.31M	Hold	37,500	–	–	0.06%	58
2017 Q4	$6.13M	Hold	37,500	–	–	0.05%	62
2017 Q3	$7.69M	Sell	37,500 -128,500	-77%	-$29.9M	0.07%	60
2017 Q2	$40.4M	Buy	166,000 +91,000	+121%	+$21.4M	0.3%	55
2017 Q1	$17.9M	Sell	75,000 -400,000	-84%	-$93.2M	0.17%	58
2016 Q4	$99.8M	Buy	475,000 +75,000	+19%	+$15.5M	0.83%	33
2016 Q3	$92.1M	Hold	400,000	–	–	0.86%	36
2016 Q2	$92.4M	Buy	+400,000	New	+$92.2M	0.81%	36
2016 Q1	–	Sell	-407,087	Closed	-$127M	–	88
2015 Q4	$127M	Buy	+407,087	New	+$121M	1.1%	29

Other funds holding AGN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $6.16B AUM 3.55% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return

Highfields Capital Management's AGN Position: Q4 2018 in Review

Highfields Capital Management sold out of Allergan plc (AGN) in Q4 2018, closing a stake of 37,500 shares — an estimated $7.14M sold.

Highfields Capital Management first reported a position in AGN in Q4 2015 and held it in 11 quarters. The position peaked at $127M in Q4 2015. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.

Highfields Capital Management reported no remaining Allergan plc position as of Q4 2018 after selling out during the quarter.
Highfields Capital Management sold 37,500 Allergan plc shares in Q4 2018, an estimated $7.14M.
Highfields Capital Management first reported a position in Allergan plc in Q4 2015 and held it in 11 quarters.
Highfields Capital Management's Allergan plc position peaked at $127M in Q4 2015.
1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.

Based on Highfields Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.